Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585286 · ClinicalTrials.gov registry record · Phase 1
Fractional Resurfacing Device for Treatment of Acne Scarring
A Phase 1 study, sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT00585286 is a Phase 1 study that has completed, run by University of California, Irvine. The registered enrollment target is 15 participants.
The verdict
NCT00585286, a Phase 1 study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate the safety and effectiveness of a new investigational laser device for treatment of acne scarring, for improvement in the appearance of surface texture and topography (recessed or uneven surfaces).
Interventions
- DEVICE 10,600 nm fractional carbon dioxide laser system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00585286
The ClinicalTrials.gov registry entry for NCT00585286 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 10,600 nm fractional carbon dioxide laser system is the first listed.
NCT00585286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00585286 about?
NCT00585286 is a clinical study titled "Fractional Resurfacing Device for Treatment of Acne Scarring". The purpose of this research study is to evaluate the safety and effectiveness of a new investigational laser device for treatment of acne scarring, for improvement in the appearance of surface texture and topography (recessed or uneven surfaces).
What is the current status of trial NCT00585286?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2007-03. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00585286?
The interventions under investigation include: 10,600 nm fractional carbon dioxide laser system (DEVICE).
Who is sponsoring clinical trial NCT00585286?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.